The Transgenic Core provides all of our Projects with state-of-the-art tools to enable manipulation of specific genes of interest in brain reward regions in the context of animal models of drug abuse and addiction. Centralizing these functions within a single Core derives substantial cost savings and ensures the proper and rigorous use of these approaches. First, numerous lines of transgenic and knockout mice, generated by PPG investigators or obtained from other laboratories, are required for the PPG's research. The Core is responsible for breeding, genotyping, and maintaining the progeny for use by the individual Projects, as well as providing the appropriate control mice. Careful consideration is given to genetic background and we use wildtype littermate controls for all experiments. The Core is also responsible for generating several new lines of transgenic and knockout mice required for the proposed program of research. Prominent among the existing and proposed new mouse lines are those that manipulate the expression of specific genes both temporally and spatially, i.e., inducible and cell-targeted mutations. Our group has substantial experience with these methods, which include use of the tetracycline gene regulation system and the Cre-loxP system. Indeed, Core research has succeeded in developing truly inducible, cell-targeted gene knockouts in brain reward regions. Second, the Core provides Project investigators with vectors for viral-mediated gene transfer, a crucial tool used in our research program. PPG investigators have played a leading role nationally in these efforts, and now routinely use Herpes simplex and Adeno-associated viral vectors. This work includes viral expression of Cre recombinase to induce highly localized knockouts in brain, and the expression of small hairpin RNA's to induce knockdowns of genes via an RNA interference (RNAi) mechanism. We are very proud of the Core's achievements over the past 4 years, and we will work during the next Grant period to introduce further innovations in mouse mutagenesis and viral gene transfer for studies of the molecular basis of drug addiction.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-RXL-E)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
New York
United States
Zip Code
Steinberg, Elizabeth E; Christoffel, Daniel J; Deisseroth, Karl et al. (2015) Illuminating circuitry relevant to psychiatric disorders with optogenetics. Curr Opin Neurobiol 30:16-Sep
Walker, Deena M; Cates, Hannah M; Heller, Elizabeth A et al. (2015) Regulation of chromatin states by drugs of abuse. Curr Opin Neurobiol 30:112-21
Koo, Ja Wook; Lobo, Mary Kay; Chaudhury, Dipesh et al. (2014) Loss of BDNF signaling in D1R-expressing NAc neurons enhances morphine reward by reducing GABA inhibition. Neuropsychopharmacology 39:2646-53
Peña, Catherine J; Bagot, Rosemary C; Labonté, Benoit et al. (2014) Epigenetic signaling in psychiatric disorders. J Mol Biol 426:3389-412
Heller, Elizabeth A; Cates, Hannah M; Peña, Catherine J et al. (2014) Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors. Nat Neurosci 17:1720-7
Maze, Ian; Chaudhury, Dipesh; Dietz, David M et al. (2014) G9a influences neuronal subtype specification in striatum. Nat Neurosci 17:533-9
Maze, Ian; Shen, Li; Zhang, Bin et al. (2014) Analytical tools and current challenges in the modern era of neuroepigenomics. Nat Neurosci 17:1476-90
Arango-Lievano, Margarita; Schwarz, Justin T; Vernov, Mary et al. (2014) Cell-type specific expression of p11 controls cocaine reward. Biol Psychiatry 76:794-801
Feyder, Michael; Södersten, Erik; Santini, Emanuela et al. (2014) A Role for Mitogen- and Stress-Activated Kinase 1 in L-DOPA-Induced Dyskinesia and ?FosB Expression. Biol Psychiatry :
Dong, Yan; Nestler, Eric J (2014) The neural rejuvenation hypothesis of cocaine addiction. Trends Pharmacol Sci 35:374-83

Showing the most recent 10 out of 179 publications